small molecule

ALKINDI SPRINKLE

HYDROCORTISONE

Loss of exclusivityMay 2034latest FDA-listed patent expiry
CompanyEton PharmaceuticalsView the full company profile on CliffBio

Drug detail

Brand nameALKINDI SPRINKLE
Active ingredientHYDROCORTISONE
Strength5MG
Dosage formGRANULE
RouteORAL
ModalitySmall molecule
FDA approvalSeptember 2020
Marketing statusRX

Listed patents

PatentExpiresType
9649280May 2034product
9675559January 2033use U-3075
9717740November 2032use U-3075

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

ALKINDI SPRINKLE patent cliff — loss of exclusivity May 2034 | CliffBio